Showing results (11-20 of 871) with videos related to
Sort By:
Pageof 88
Clinical Immunology (Orlando, Fla.)|December 21, 2010
Temporal dynamics of anti-MOG antibodies in CNS demyelinating diseasesFranziska Di Pauli, Simone Mader, Kevin Rostasy, et al.Journal of Neuroimmunology|October 19, 2006
Increased serum levels of soluble CD14 indicate stable multiple sclerosisAndreas Lutterotti, Bettina Kuenz, Viktoria Gredler, et al.Multiple Sclerosis and Related Disorders|September 21, 2016
Rethinking the importance of paroxysmal and unusual symptoms as first clinical manifestation of multiple sclerosis: They do matterRainer Ehling, Gabriel Bsteh, Franziska Di Pauli, et al.Journal of the Neurological Sciences|October 16, 2009
Features of intrathecal immunoglobulins in patients with multiple sclerosisFranziska Di Pauli, Viktoria Gredler, Bettina Kuenz, et al.Journal of Neuroimmunology|August 29, 2006
Antibodies as biological markers for pathophysiological processes in MSMarkus Reindl, Michael Khalil, Thomas BergerCurrent Medicinal Chemistry|August 21, 2007
Biological markers for multiple sclerosisAndreas Lutterotti, Thomas Berger, Markus ReindlResults and Problems in Cell Differentiation|June 11, 2009
B cells and antibodies in MSMarkus Reindl, Bettina Kuenz, Thomas BergerBrain Pathology (Zurich, Switzerland)|May 5, 2010
A 45-year old male with left-sided hemihypesthesiaRainer Ehling, William Sterlacci, Hans Maier, et al.Plos One|August 5, 2017
Cerebrospinal fluid B cells and disease progression in multiple sclerosis - A longitudinal prospective studySebastian Wurth, Bettina Kuenz, Gabriel Bsteh, et al.Multiple Sclerosis and Related Disorders|March 11, 2018
New clinical implications of anti-myelin oligodendrocyte glycoprotein antibodies in children with CNS demyelinating diseasesFranziska Di Pauli, Markus Reindl, Thomas BergerPageof 88